NanoInk Launches Life Sciences Division | GenomeWeb
NEW YORK (GenomeWeb News) – Nanotechnology firm NanoInk today said that it has launched a new division called NanoBioDiscovery that will focus on supplying technologies for biomarker research and drug discovery.
 
The Skokie, Ill.-based firm said that the new division will use its Dip Pen Nanolithography nanofabrication techniques and detection systems to produce assays for protein discovery and identification. It believes its technology can provide researchers with enhanced reaction kinetics and assay cost savings.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.